Surgical Mesh And Sling Devices Must Undergo Post-Market Studies
By
Rebecca Kern / Email the Author / “The Gray Sheet” Jan. 9, 2012, Vol. 38, No. 02
Regulatory / Word Count: 670 / Article # 01120109019
Executive Summary
FDA sends post-market study orders to 33 manufacturers of urogynecologic surgical mesh used for pelvic organ prolapse and to seven makers of single-incision mini-slings used for stress urinary incontinence.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.